Peterson Kristine
ArriVent BioPharma, Inc. · Director
Peterson Kristine is listed in filings as Director at ArriVent BioPharma, Inc.. This profile follows SEC Form 4 activity through Jun 22, 2026, including 6 public disclosures. Recent filings connect the profile to ArriVent BioPharma, Inc. (AVBP), Immunocore Holdings plc (IMCR), and Enanta Pharmaceuticals Inc (ENTA). The current snapshot covers public activity from Mar 14, 2025 to Jun 22, 2026. Reported amounts are shown as $430.5K to $107.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||